Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation : a multicentre, randomised, phase 3 trial

Sandmaier, Brenda M.; Kornblit, Brian; Storer, Barry E.; Olesen, Gitte; Maris, Michael B.; Langston, Amelia A.; Gutman, Jonathan A.; Petersen, Soeren L.; Chauncey, Thomas R.; Bethge, Wolfgang A.; Pulsipher, Michael A.; Woolfrey, Ann E.; Mielcarek, Marco; Martin, Paul J.; Appelbaum, Fred R.; Flowers, Mary E. D.; Maloney, David G.; Storb, Rainer

Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation : a multicentre, randomised, phase 3 trial

Autor(en):

Sandmaier, Brenda M.; Kornblit, Brian; Storer, Barry E.; Olesen, Gitte; Maris, Michael B.; Langston, Amelia A.; Gutman, Jonathan A.; Petersen, Soeren L.; Chauncey, Thomas R.; Bethge, Wolfgang A.; Pulsipher, Michael A.; Woolfrey, Ann E.; Mielcarek, Marco; Martin, Paul J.; Appelbaum, Fred R.; Flowers, Mary E. D.; Maloney, David G.; Storb, Rainer

Tübinger Autor(en):

Bethge, Wolfgang Andreas

Erschienen in:

Lancet Haematology (2019), Bd. 6, H. 8, S. E409-E418

Verlagsangabe:

Elsevier Sci Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/S2352-3026(19)30088-2

ISSN:

2352-3026